Physician

Maath Alani, MD

According to 2025 Medicare claims, Maath Alani, MD (NPI: 1518250133) practices internal medicine in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is GHASSAN A ATTO MD PLLC (NPI: 1932457546; TIN: 454703805) and primary practice location at 48193-7509. Alani is affiliated with the Elite Patient Care, LLC (ACO ID: A5069) and PCMA Cooperative LLC (ACO ID: D0290), participating under both the MSSP and REACH models.

Alani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 861 traditional Medicare patients, billed 7,511 HCPCS/CPT codes, and received $441,169 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 20,612 prescription claims across 1,202 beneficiaries totaling $2,330,286 in drug costs, led by Eliquis (Apixaban). DME data shows 285 claims. Open Payments data shows 20 records totaling $299. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $61,912 to $441,169. Similarly, Part D prescription costs have moved sharply higher in recent years, from $27,771 to $2,330,286. In contrast, DME billing represents a smaller volume and rose steadily, from $1,179 to $19,504.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	423	682	$61,912
2016	531	2,287	$167,079
2017	740	4,506	$310,843
2018	854	5,907	$348,560
2019	1,010	8,046	$454,373
2020	1,193	8,039	$491,153
2021	1,106	9,074	$555,713
2022	974	7,352	$430,490
2023	968	7,005	$397,665
2024	861	7,511	$441,169

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	488	$27,771
2016	303	1,495	$71,410
2017	510	4,394	$193,691
2018	780	12,046	$622,141
2019	827	15,199	$895,292
2020	1,039	19,706	$1,268,913
2021	1,003	20,468	$1,514,397
2022	1,082	17,644	$1,759,374
2023	1,205	18,913	$2,109,407
2024	1,202	20,612	$2,330,286

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	34	$711
2018	12	219	$6,901
2019	25	303	$9,870
2020	13	323	$23,021
2021	49	427	$12,846
2022	49	392	$20,746
2023	13	359	$20,610
2024	23	285	$11,030

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	267	353	$109
99497	Advance care planning, first 30 minutes	191	234	$69
99238	Hospital discharge day management, 30 minutes or less	231	321	$67
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	362	2,172	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	149	235	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	730	12,812	$263,934
Erleada	Apalutamide	13	294	$203,349
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	196	5,732	$122,874
Ingrezza	Valbenazine Tosylate	26	364	$106,253
Ozempic	Semaglutide	72	2,454	$80,291

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	74	$5,345
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	13	$2,077
E1392	Portable oxygen concentrator, rental	Y	N/R	35	$1,141
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	18	$801
K0001	Standard wheelchair	Y	12	47	$659

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$299	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maath Alani, MD?

Tedicare shows public-source Medicare data for Maath Alani, MD (NPI 1518250133), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maath Alani, MD have ACO affiliation data?

Maath Alani, MD is shown with ACO affiliation data for Elite Patient Care, LLC (MSSP, ACO ID A5069) and PCMA Cooperative LLC (REACH, ACO ID D0290).

What billing organization is linked to Maath Alani, MD?

Maath Alani, MD is linked to GHASSAN A ATTO MD PLLC (billing NPI 1932457546) in the available physician profile data.

Does Maath Alani, MD have Open Payments data?

Maath Alani, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.